Cantor Fitzgerald Initiates Coverage On Electra Therapeutics with Overweight Rating

Cantor Fitzgerald analyst Eric Schmidt has initiated coverage on Electra Therapeutics (NASDAQ: ETRA) with an Overweight rating. This marks a significant endorsement for the company as it seeks to attract investor interest.